The legislation widely known as the Creating and Restoring Equal Access to Equivalent Samples Act (CREATES Act), signed into law as part of the year-end appropriations legislation, is a long-anticipated provision that aims to make samples of brand drugs or biologics needed for pre-approval testing more readily available to generic companies. The CREATES Act authorizes manufacturers seeking to develop generic 505(b)(2) or biosimilar products  to file civil action against brand drug or biologic manufacturers to obtain samples. This webinar will summarize the provisions of the CREATES Act and discuss its potential impact on the generics, biosimilar, and brand name drug industries.


Sharon Coleman, Senior Regulatory Counsel, FDA – CDER
Karin Hessler, Associate General Counsel, Association for Accessible Medicines
Andrew Wasson, Partner, Haug Partners LLP
Moderated by Rachel Turow, Executive Counsel, Regulatory Law, TEVA Pharmaceuticals USA, Inc. and Member, FDLI Board of Directors



  • +$100 for non-members

Webinar & Recording

  • +$100 for non-members
Register Now


Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you in your purchase.

An access link will be provided to attendees via email upon registration.

If you are registering on behalf of someone else, the link to access the webinar will go to the email address provided at the point of registration.

Those registering on the day of the webinar will receive an access link via email upon successful payment.

Please click the Test Your System link to determine your computer’s compatibility prior to the webinar.

Your organization may have strict IT policies that impede your ability to participate in the webinar. If you believe that may be the case, please perform the diagnostic test prior to purchasing a registration.

Yes! You may participate in the webinar from any contemporary smart phone or tablet. This requires a stable WIFI or data connection.

Please click the Test Your System link to determine your device’s compatibility prior to the webinar.

No, webinar content including audio is streamed through your computer or mobile device.

Please click the Test Your System link to determine your device’s compatibility prior to the webinar.

Webinar recordings are sent via email as soon as we are able to process and verify the quality of the recording. This usually occurs within 3 business days of a webinar broadcast.

If multiple people at your organization wish to participate from separate devices, each will be required to purchase access.